These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16022084)

  • 61. Treatment of infections caused by antimicrobial-resistant gram-positive bacteria.
    Kinney KK
    Am J Med Sci; 2010 Sep; 340(3):209-17. PubMed ID: 20823699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Which antibiotic for resistant Gram-positives, and why?
    Bradley JS
    J Infect; 2014 Jan; 68 Suppl 1():S63-75. PubMed ID: 24188585
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vancomycin-resistant peritonitis associated with peritoneal dialysis: a cause for concern.
    O'Riordan A; Abraham KA; Ho JK; Walshe JJ
    Ir J Med Sci; 2002; 171(1):42-3. PubMed ID: 11993595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isolation of bacterial DNA followed by sequencing and differing cytokine response in peritoneal dialysis effluent help in identifying bacteria in culture negative peritonitis.
    Prasad N; Singh K; Gupta A; Prasad KN
    Nephrology (Carlton); 2018 Feb; 23(2):148-154. PubMed ID: 27859980
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
    Tsoulas C; Nathwani D
    Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria.
    Tang SS; Apisarnthanarak A; Hsu LY
    Adv Drug Deliv Rev; 2014 Nov; 78():3-13. PubMed ID: 25134490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of gram-positive bacterial infections in patients with cancer.
    Kosmidis CI; Chandrasekar PH
    Leuk Lymphoma; 2012 Jan; 53(1):8-18. PubMed ID: 21740298
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacoeconomics of treatment with the newer anti-Gram-positive agents.
    Wang L; Barrett JF
    Expert Opin Pharmacother; 2006 May; 7(7):885-97. PubMed ID: 16634711
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
    Liu J; Huang X; Liu Y; Xu H; Gong R; Li C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1328-1333. PubMed ID: 28070047
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Bacteriological characteristics of the peritoneal dialysis fluid infections].
    Jellouli M; Ferjani M; Abidi K; Hammi Y; Abdallah TB; Gargah T
    Pan Afr Med J; 2015; 22():162. PubMed ID: 26893796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
    Rolston KV; Kapadia M; Tarrand J; Coyle E; Prince RA
    Int J Antimicrob Agents; 2013 Jun; 41(6):516-20. PubMed ID: 23481658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current and emerging serious Gram-positive infections.
    Menichetti F
    Clin Microbiol Infect; 2005 May; 11 Suppl 3():22-8. PubMed ID: 15811021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective study.
    Piroth L; Pechinot A; Minello A; Jaulhac B; Patry I; Hadou T; Hansmann Y; Rabaud C; Chavanet P; Neuwirth C
    Scand J Infect Dis; 2009; 41(11-12):847-51. PubMed ID: 19922067
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evolving resistance among Gram-positive pathogens.
    Munita JM; Bayer AS; Arias CA
    Clin Infect Dis; 2015 Sep; 61 Suppl 2(Suppl 2):S48-57. PubMed ID: 26316558
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
    Mendes RE; Deshpande LM; Jones RN
    Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.